• Genomic Testing and ALK Alterations

  • Apr 10 2023
  • Length: 18 mins
  • Podcast

Genomic Testing and ALK Alterations

Listen for free

View show details

  • Summary

  • On episode 8 of Oncology Hour, we discuss ALK alterations in cancer and genomic testing. ALK Alterations appear in lung cancer, lymphoma, and childhood cancer. ALK inhibitors are treatments that target ALK alterations in cancer patients. Today's guests are pediatric oncologists Dr. Jason Freedman and Dr. Ted Laetsch. Dr. Jason Freedman specializes in pediatric oncology and has contributed to the development of clinical guidelines to standardize management of symptoms. Dr Ted Laetsch leads clinical and translational research evaluating novel targeted and immunotherapies for children with high-risk and often ultra-rare cancers.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Genomic Testing and ALK Alterations

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available